Disease/Infection News

RSS

AIDS United awards new grants to improve lives of people with HIV/AIDS

Thousands of individuals living with HIV/AIDS in low-income and/or rural areas will now receive local, high quality care, thanks to new grants awarded by AIDS United for its Access to Care initiative.

5 Feb 2011

Dermatologists urge athletes to be aware of most common skin infections

Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.

5 Feb 2011

Roche launches cobas TaqScreen DPX Test for parvovirus B19 and hepatitis A virus

Roche announced today that the cobas® TaqScreen DPX Test for use on the cobas s 201 system is now available in the US. It is the first commercial test to quantify parvovirus B19 and detect hepatitis A virus (HAV) simultaneously in one assay in human plasma.

5 Feb 2011

Newly identified mosquito subspecies highly susceptible to malaria parasite, prefers outdoors

"Researchers have discovered a previously unknown subspecies of mosquito in West Africa that is highly susceptible to the malaria parasite and whose existence may stymie efforts to eradicate the deadly disease," the Los Angeles Times reports (Khan, 2/4).

5 Feb 2011

Jungle Brolly launches new natural line of non alcoholic industrial hand sanitizers

Natural hand sanitizers prove a viable alternative to chemical-based hand sanitizers. In today's world, we are surrounded by a multitude of bacteria, germs, and viruses, as well as stories of new strains of those viruses, leading to serious illnesses and, in some cases, even death. In response, we seek convenient and more effective ways to protect ourselves.

4 Feb 2011

Research roundup: Comparing profit and nonprofit hospice care; Hospital mortality and spending; High-deductible insurance plans

Association Of Hospice Agency Profit Status With Patient Diagnosis, Location of Care, and Length of Stay - "The current Medicare Hospice Benefit reimburses hospices at a fixed per diem rate that does not consider the patient's diagnosis, location of care, or hospice LOS [length-of-stay]," and as such, "profit can be maximized by caring for patients with certain diagnoses that require fewer skilled services, patients residing in nursing homes, or patients with longer hospice stays."

4 Feb 2011

Dermatologists offer preventative tips to minimize pesky skin problems caused by plants

What may start as a seemingly harmless day of gardening or yard work can quickly take a turn for the worse when common plants make their mark on the skin, causing a host of mild to even severe skin reactions. That is why dermatologists are arming outdoor enthusiasts with preventative tips to keep these perils of the great outdoors at arm's length.

4 Feb 2011

Queen's awarded £1.74 million grant to study microbiology of Cystic Fibrosis pulmonary infection

Scientists at Queen's University Belfast have begun work into improving the lives of thousands of Cystic Fibrosis sufferers thanks to the award of a £1.74 million US-Ireland Research and Development Partnership grant.

4 Feb 2011

Report examines how health worker shortages could keep developing countries from achieving universal access to HIV/AIDS prevention, treatment

A shortage of healthcare workers in developing countries may hold developing countries back from achieving the U.N. Millennium Development Goal to achieve universal access to HIV/AIDS treatment by 2015, according to a report by the WHO/Global Health Workforce Alliance, IRIN/PlusNews writes.

4 Feb 2011

Study finds total cost of dengue illness in Americans to be $2.1 billion per annum

The first assessment of the total cost of dengue illness in the Americas reveals the economic burden to be approximately $2.1 billion per year, exceeding that from other viral illnesses including human papillomavirus and rotavirus.

4 Feb 2011

AHF urges all AIDS drug manufacturers to reduce medication cost by 20%

As part of its ongoing advocacy to lower drug prices and increase access to lifesaving medications AIDS Healthcare Foundation, the largest global AIDS organization, today urged all AIDS drug manufacturers to reduce the cost of their medications by 20% for cash-strapped state.

4 Feb 2011

Cell signaling hormone boosts immune response to clear HIV-like infection

Australian scientists have successfully cleared a HIV-like infection from mice by boosting the function of cells vital to the immune response.

4 Feb 2011

Tacere announces reacquisition of HCV compound development, commercialization rights in Asia

Tacere Therapeutics, an RNA interference (RNAi)-based therapeutics company, announced today that it has reacquired the development and commercialization rights to its Hepatitis C Virus compounds throughout Asia from its strategic partner, Tokyo-based Oncolys BioPharma Inc.

4 Feb 2011

FIND, Cepheid collaborate to develop rapid molecular test for measurement of HIV viral load

Cepheid and FIND today announced a new collaboration to accelerate the development of a rapid molecular test for the measurement of human immunodeficiency virus viral load.

3 Feb 2011

Stockpiling flu drugs, vaccines reduces impact of pandemic, but option out of reach for most countries, study finds

"Stockpiling antiviral flu drugs and vaccines saves lives and reduces disease in a flu pandemic," but the cost to maintain such a stockpile and deploy interventions in the event of an outbreak "is too expensive for around two thirds of the world's population, scientists said on Wednesday," Reuters reports.

3 Feb 2011

Public health experts: Improved community engagement needed to prevent pandemic spread

In the current issue of Journal of Public Health Management and Practice, public health experts assert that improved community engagement is needed to prevent the spread of pandemics.

3 Feb 2011

New England Journal publishes fidaxomicin Phase 3 trial results against CDI

Optimer Pharmaceuticals, announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection.

3 Feb 2011

First therapeutic vaccine designed from dendritic cells of patient achieves significant response

The therapeutic vaccines are a priority research line of the HIVACAT, the catalan programme for the development of therapeutic vaccines and prevention against the Human Immunodeficiency Virus (HIV). This type of therapeutic vaccine helps the patients who are carriers of the virus, combat infection and control the appearance of AIDS in the same way as with the current antiretroviral treatments.

3 Feb 2011

Intermittent use of preventive malaria drugs in children found to help prevent malaria transmission, studies say

Three studies published on Tuesday in PLoS Medicine show that "intermittent use of preventive antimalarial drugs can be beneficial in curbing the spread of the disease in children," Agence France-Presse reports (2/1).

3 Feb 2011

Malaria transmission to decline in Burundi because of global warming

Malaria transmission will not increase because of global warming in the African nation of Burundi according to a statistical analysis by researchers in Austria and Burundi. Writing in the International Journal of Global Warming, the team explains that rising temperatures will lead to lower humidity and rainfall which will shorten the lifespan of mosquitoes carrying malaria.

3 Feb 2011

Disease/Infection News

AIDS United awards new grants to improve lives of people with HIV/AIDS

Dermatologists urge athletes to be aware of most common skin infections

Roche launches cobas TaqScreen DPX Test for parvovirus B19 and hepatitis A virus

Newly identified mosquito subspecies highly susceptible to malaria parasite, prefers outdoors

Jungle Brolly launches new natural line of non alcoholic industrial hand sanitizers

Research roundup: Comparing profit and nonprofit hospice care; Hospital mortality and spending; High-deductible insurance plans

Dermatologists offer preventative tips to minimize pesky skin problems caused by plants

Queen's awarded £1.74 million grant to study microbiology of Cystic Fibrosis pulmonary infection

Report examines how health worker shortages could keep developing countries from achieving universal access to HIV/AIDS prevention, treatment

Study finds total cost of dengue illness in Americans to be $2.1 billion per annum

AHF urges all AIDS drug manufacturers to reduce medication cost by 20%

Cell signaling hormone boosts immune response to clear HIV-like infection

Tacere announces reacquisition of HCV compound development, commercialization rights in Asia

FIND, Cepheid collaborate to develop rapid molecular test for measurement of HIV viral load

Stockpiling flu drugs, vaccines reduces impact of pandemic, but option out of reach for most countries, study finds

Public health experts: Improved community engagement needed to prevent pandemic spread

New England Journal publishes fidaxomicin Phase 3 trial results against CDI

First therapeutic vaccine designed from dendritic cells of patient achieves significant response

Intermittent use of preventive malaria drugs in children found to help prevent malaria transmission, studies say

Malaria transmission to decline in Burundi because of global warming

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Latest News